BIT 2.70% 3.8¢ biotron limited

No, though her focus on the scourge of HIV (and her optimism) is...

  1. 2,021 Posts.
    lightbulb Created with Sketch. 307
    No, though her focus on the scourge of HIV (and her optimism) is highlighted. She reiterated that as it currently stands, once on HIV treatment, the treatment is for life.

    No way she'd mention anything price sensitive and commercially-focused companies or drugs at the development stage.

    Dr Lewin was a consultant for Biotron's BIT225.
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.8¢
Change
0.001(2.70%)
Mkt cap ! $34.28M
Open High Low Value Volume
3.7¢ 4.0¢ 3.7¢ $68.85K 1.794M

Buyers (Bids)

No. Vol. Price($)
2 150000 3.7¢
 

Sellers (Offers)

Price($) Vol. No.
4.0¢ 349950 3
View Market Depth
Last trade - 15.10pm 28/06/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.